KNL1 (cancer susceptibility candidate 5)
2016-10-01 Masato Takimoto  , Jean-Loup Huret   AffiliationInstitute for Genetic Medicine, Hokkaido University, Sapporo, Hokkaido, Japan
Identity
Abstract
Review on KNL1, with data on DNA, on the protein encoded, and where the gene is implicated.
DNA/RNA
Note
Transcription
Analysis on testis mRNA shows two bands with size of approximately 6 and 8,5 kb which are probably derived from the two isoforms.
Proteins

Description
The KLN1 protein contains: conserved motifs, which are the following: a (S/G)ILK motif (aa 25-28), a RRVSF motif (aa 57-61), and, for BUB3 recognition, MELT repeats (aa 140-161, 308-329, 474-494, 562-582, 750-769, 859-882, 902-924, 940-962, 1025-1044, 1073-1096, 1114-1136, 1152-1174). The Bubs recognition KI motifs KI(D/N)XXXF(L/I)XXLK, are KIDTTSFLANLK (aa 202-213) for BUB1, and KIDFNDFIKRLK (aa 238-249) for BUB1B: (BUBR1); a nuclear localization signal (aa 1789-1803); a coiled coil region (aa 1942-2133) and the ZWINT (Zwint-1) binding region (aa 1834 or 19811 for a smaller region -2108); and RWD repeats (aa 2109- 2353) With the NSL1 (hMis14)-binding region (aa 2109-2316), according to Kiyomitsu et al., 2011, VEGA checking, and SwissProt.
Expression
Localisation
In mitosis KNL1 protein is localized in kinetochore in a human cancer cell line.
Function
The depletion preclude metaphase chromosomal congression, while in yeast, Drosophila and human cells, the depletions show partial alignment phenotypes, in which some chromosomes congress to the equator but many chromosomes remain stranded near the spindle poles. In the N-terminus of KNL1 protein, AURKB (Aurora kinase B) phosphorylates SILK and RVSF motifs, and then disrupts the interaction between KNL1 and protein phosphatase I (PP1), which also binds the motifs. KNL1 augments Aurora B kinase activity that phosphorylates outer kinetochore protein, such as NDC80, resulting in reduction its microtubule-binding activity. Protein phosphatase 2A ( PP2A) is recruited by BUB1B (BubR1), one of SAC protein. Both PP1 and PPA2 are suggested to counteract Aurora B kinase activity. Especially, PP1 was shown to stabilize microtubule attachments to kinetochores probably through KNL1, while Aurora B kinase destabilizes microtubule-binding by NDC80 phosphorylation as described. The destabilized binding of KNL1 to microtubules is presumably important for correcting and eliminating erroneous kinetochore-microtubule attachment during SAC.
It is suggested that the bindings with microtubule and with PP1 also play roles in SAC silencing. Although their binding sites are in close proximity, one of their bindings do not affect the other, and they contribute independently to the silencing of SAC. Two KI motifs, KI1 and KI2, localized in the N-terminus, bind SAC protein, BUB1 and BUB1B, respectively, through tetratricopeptide repeats (TPRs) of the proteins, resulting into folding the motifs into short alpha-helices. Although BUB1 fragment with mutation in KI-binding domain was not able to bind to KNL1 in vitro, BUB1 and BUB1B mutants with KI-binding sites were able to attach to kinetochore. Mutations in the BUB3-binding domain (BUB3-BD) in BUB1 and BUB1B prevent kinetochore localization of the SAC protein. BUB1 fragment consisting only of N-terminus with TPRs does not localize to kinetochore and longer fragments that accommodate BUB3-BD did. Those results suggest that BUB3-BD of BUB1 and BUB1B, rather than TPRs, is critical for their recruitment to kinetochore and that the interaction between TPRs of Bub proteins and KI-motif of KNL1 might play a subsidiary role in the localization of BUB1 and BUB1B to kinetochore. In response to SAC signal, the first step of this response is phosphorylation of MELT motifs of KNL1, located in the N-terminal and central region, by Mps1 kinase, and then the phosphorylated MELT motifs bind BUB3/BUB1complex, mediating SAC signaling. KNL1- BUB3-BUB1(KBB) complex binds MXD1 (MAD1)/ MAD2L1 (MAD2) complex, and then, together with MAD1 phosphorylation by Msp1, the binding leads to CDC20/MAD2 formation, an essential part of Mitotic Checkpoint Complex (MCC) that inhibits Anaphase Promoting Complex/Cyclosome (APC/C).
Recently, it suggested that there are two pathways for recruiting MAD1-MAD2 that results in SAC activation. One is the pathway through KBB, as described above, the other is KNTC1 (ROD)-RW10- ZWILCH, (RZZ) complex, which interacts with KNL1 through ZWINT (Zwint-1 protein). The former is required for SAC activation when kinetochores are misaligned but is not essential when kinetochores are unattached from microtubules. The latter binds SPDL1 (Spindly protein) and MAD1-MAD2, and causes the anaphase-onset delay in response to unattached kinetochore independently of the former.
It was suggested that the binding of KNL1 with microtubules and with PP1 contribute to silencing of SAC, in which motor protein dynein, moving along on microtubules, is suggested to work to strip MAD1-MAD2. The C-terminal region of KNL1 interacts with MIS12 and Zwint-1 protein, through RWD motif and coiled-coiled region, respectively. The binding with the former plays role in connecting inner kinetochore with KNL1 and the latter mediates the interaction of KNL1 with RZZ complex which works in SAC regulation as described above.
Implicated in
t(11;15)(q23;q14-15)
Data on 16 cases with a t(11;15)(q23;q14-15), according to (Yang et al., 2014) are the following: there was 2 of myelodysplastic syndrome (MDS) cases, 10 acute myeloid leukemia (AML) cases (2 M1, 4 M2, 3 M4, and 1 NOS), and 4 acute lymphoblastic leukemia (ALL) cases. Mean age of the patients was 20.6 years (range 1-54); there were 11 males and 5 females. Abnormalities of chromosome 3 were seen in 10 out of 16 cases. Out of 8 patients for whom clinical data were available, only 3 are in complete remission, whereas 5 patients died with a mean survival period of 10.4 months.
t(11;15)(q23;q15) and KMT2A/KNL1
Of 7 cases with a t(11;15)(q23;q15) and KMT2A/KNL1 hybrid gene and fusion protein ((Chinwalla et al., 2003; Kuefer et al., 2003; Meyer et al., 2006; Yang et al., 2014). Diagnosis was: therapy related MDS (t-MDS) in 2 cases, AML in 4 cases (1 M2, 2 AML-M4, 1 AML-NOS), and 1 de novo T-ALL. Sex ratio was 5M:1F; There was 3 children and 4 adult patients. Of three cases with data on survival, patients died at: 8 mths, 8 mths, and 22 mths. Of four cases with documented karyotypes: the karyotype was a complex karyotype with markers in two cases, abnormalities of chromosome 3 were seen in three cases, +21 in two cases. KMT2A (MLL) exon 8, 9, or 10 were fused to exon 10, 11 or 12 of KNL1, the fusion protein contains the 1362 or 1418 first aa from MLL with aa 1796, 1818 or 1819 from KNL1 (according to authors and/or VEGA).
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|
| 10694877 | 2000 | Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. | Blencowe BJ et al |
| 24456977 | 2014 | Kinetochore signalling: the KIss that MELTs Knl1. | Bollen M et al |
| 24310619 | 2014 | KNL1: bringing order to the kinetochore. | Caldas GV et al |
| 12618766 | 2003 | A t(11;15) fuses MLL to two different genes, AF15q14 and a novel gene MPFYVE on chromosome 15. | Chinwalla V et al |
| 25747656 | 2015 | The (phospho) needle in the (MELT) Haystack. | Faesen AC et al |
| 22983954 | 2012 | Kinetochore KMN network gene CASC5 mutated in primary microcephaly. | Genin A et al |
| 27899596 | 2017 | ChiTaRS-3.1-the enhanced chimeric transcripts and RNA-seq database matched with protein-protein interactions. | Gorohovski A et al |
| 10521316 | 1999 | Primary autosomal recessive microcephaly: homozygosity mapping of MCPH4 to chromosome 15. | Jamieson CR et al |
| 20232224 | 2010 | Finding the middle ground: how kinetochores power chromosome congression. | Kops GJ et al |
| 12618768 | 2003 | Characterization of the MLL partner gene AF15q14 involved in t(11;15)(q23;q14). | Kuefer MU et al |
| 16511515 | 2006 | The MLL recombinome of acute leukemias. | Meyer C et al |
| 26651294 | 2015 | KNL1-Bubs and RZZ Provide Two Separable Pathways for Checkpoint Activation at Human Kinetochores. | Silió V et al |
| 11792804 | 2001 | Kinetochore localisation and phosphorylation of the mitotic checkpoint components Bub1 and BubR1 are differentially regulated by spindle events in human cells. | Taylor SS et al |
| 24425691 | 2014 | Molecular characterization and clinical impact of t(11;15)(q23;q14-15) MLL-CASC5 rearrangement. | Yang JJ et al |
Other Information
Locus ID:
NCBI: 57082
MIM: 609173
HGNC: 24054
Ensembl: ENSG00000137812
Variants:
dbSNP: 57082
ClinVar: 57082
TCGA: ENSG00000137812
COSMIC: KNL1
RNA/Proteins
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37937525 | 2024 | A novel KNL1 intronic splicing variant likely destabilizes the KMN complex, causing primary microcephaly. | 0 |
| 38583438 | 2024 | Kinetochore scaffold 1 downregulation suppressed the development of non-small cell lung cancer by inactivating the phosphatidylinositol 3 kinase/protein kinase B (AKT)/nuclear factor-kappa B pathway. | 0 |
| 37937525 | 2024 | A novel KNL1 intronic splicing variant likely destabilizes the KMN complex, causing primary microcephaly. | 0 |
| 38583438 | 2024 | Kinetochore scaffold 1 downregulation suppressed the development of non-small cell lung cancer by inactivating the phosphatidylinositol 3 kinase/protein kinase B (AKT)/nuclear factor-kappa B pathway. | 0 |
| 33566033 | 2021 | [CASC5 Gene Expression Changes Correlate with Targeted Mutations in Leukemia]. | 1 |
| 33566033 | 2021 | [CASC5 Gene Expression Changes Correlate with Targeted Mutations in Leukemia]. | 1 |
| 32283571 | 2020 | CASC5 is a potential tumour driving gene in lung adenocarcinoma. | 8 |
| 32795273 | 2020 | LINC02418 promotes malignant behaviors in lung adenocarcinoma cells by sponging miR-4677-3p to upregulate KNL1 expression. | 8 |
| 32283571 | 2020 | CASC5 is a potential tumour driving gene in lung adenocarcinoma. | 8 |
| 32795273 | 2020 | LINC02418 promotes malignant behaviors in lung adenocarcinoma cells by sponging miR-4677-3p to upregulate KNL1 expression. | 8 |
| 30655516 | 2019 | LUBAC controls chromosome alignment by targeting CENP-E to attached kinetochores. | 13 |
| 31315522 | 2019 | Effect of KNL1 on the proliferation and apoptosis of colorectal cancer cells. | 15 |
| 30655516 | 2019 | LUBAC controls chromosome alignment by targeting CENP-E to attached kinetochores. | 13 |
| 31315522 | 2019 | Effect of KNL1 on the proliferation and apoptosis of colorectal cancer cells. | 15 |
| 30100357 | 2018 | KNL1 Binding to PP1 and Microtubules Is Mutually Exclusive. | 33 |
Citation
Masato Takimoto ; Jean-Loup Huret
KNL1 (cancer susceptibility candidate 5)
Atlas Genet Cytogenet Oncol Haematol. 2016-10-01
Online version: http://atlasgeneticsoncology.org/gene/318/knl1-(cancer-susceptibility-candidate-5)
Historical Card
2012-06-01 KNL1 (cancer susceptibility candidate 5) by Masato Takimoto  Affiliation
2006-09-01 KNL1 (cancer susceptibility candidate 5) by Masato Takimoto  Affiliation
2000-03-01 KNL1 (cancer susceptibility candidate 5) by Jean-Loup Huret,Christiane Charrin  Affiliation
